{"entity":{"type":"insider","cik":"0001500322","url":"/insider/0001500322","json_url":"/insider/0001500322.json","name":"Goldsmith Bruce A","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":11,"n_filings":7,"first":"2011-02-25","last":"2022-03-23","span_basis":"filed_date"},"name_variants":[{"name":"Goldsmith Bruce A","source":"filing","n_filings":7,"first_seen":"2011-02-25","last_seen":"2022-03-23"}],"transactions":[{"id":6751518,"accession":"0001209191-22-020791","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-22-020791","line_url":"/filing/0001209191-22-020791#line-1","is_derivative":false,"issuer_cik":"0001500322","issuer_name":"Passage BIO, Inc.","issuer_ticker":"PASG","issuer_name_source":null,"issuer_url":"/issuer/0001500322","owner_cik":"0001500322","owner_name":"Goldsmith Bruce A","owner_display_name":"Goldsmith Bruce A","owner_url":"/insider/0001500322","role":"Director, Officer (CEO and President)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CEO and President","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":10000.0,"shares_display":"10,000","price_per_share":3.15,"price_display":"3.15","price_state":"stated","total_value":31500.0,"total_display":"31,500.00","total_whole":"31,500","shares_owned_after":15983.0,"shares_owned_after_display":"15,983","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-03-21","filed_date":"2022-03-23","scope":"insider"},{"id":4893161,"accession":"0001209191-21-035051","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-21-035051","line_url":"/filing/0001209191-21-035051#line-1","is_derivative":false,"issuer_cik":"0001500322","issuer_name":"Passage BIO, Inc.","issuer_ticker":"PASG","issuer_name_source":null,"issuer_url":"/issuer/0001500322","owner_cik":"0001500322","owner_name":"Goldsmith Bruce A","owner_display_name":"Goldsmith Bruce A","owner_url":"/insider/0001500322","role":"Director, Officer (CEO and President)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CEO and President","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":2000.0,"shares_display":"2,000","price_per_share":13.115,"price_display":"13.12","price_state":"stated","total_value":26230.0,"total_display":"26,230.00","total_whole":"26,230","shares_owned_after":5983.0,"shares_owned_after_display":"5,983","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-05-21","filed_date":"2021-05-21","scope":"insider"},{"id":2680368,"accession":"0001209191-20-015623","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-20-015623","line_url":"/filing/0001209191-20-015623#line-1","is_derivative":false,"issuer_cik":"0001500322","issuer_name":"Passage BIO, Inc.","issuer_ticker":"PASG","issuer_name_source":null,"issuer_url":"/issuer/0001500322","owner_cik":"0001500322","owner_name":"Goldsmith Bruce A","owner_display_name":"Goldsmith Bruce A","owner_url":"/insider/0001500322","role":"Director, Officer (CEO and President)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CEO and President","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1100.0,"shares_display":"1,100","price_per_share":18.0,"price_display":"18.00","price_state":"stated","total_value":19800.0,"total_display":"19,800.00","total_whole":"19,800","shares_owned_after":1100.0,"shares_owned_after_display":"1,100","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-03-03","filed_date":"2020-03-03","scope":"insider"},{"id":3365985,"accession":"0001127602-12-009005","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001127602-12-009005","line_url":"/filing/0001127602-12-009005#line-3","is_derivative":false,"issuer_cik":"0001097264","issuer_name":"ALLOS THERAPEUTICS INC","issuer_ticker":"ALTH","issuer_name_source":null,"issuer_url":"/issuer/0001097264","owner_cik":"0001500322","owner_name":"Goldsmith Bruce A","owner_display_name":"Goldsmith Bruce A","owner_url":"/insider/0001500322","role":"Officer (SVP, Corporate Development)","role_mark":"O","role_mark_label":"Officer (SVP, Corporate Development)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP, Corporate Development","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4473.0,"shares_display":"4,473","price_per_share":1.4957,"price_display":"1.50","price_state":"stated","total_value":6690.2661,"total_display":"6,690.27","total_whole":"6,690","shares_owned_after":346933.0,"shares_owned_after_display":"346,933","ownership_form":"D","is_10b5_1":null,"transaction_date":"2012-03-01","filed_date":"2012-03-01","scope":"insider"},{"id":3365983,"accession":"0001127602-12-009005","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001127602-12-009005","line_url":"/filing/0001127602-12-009005#line-2","is_derivative":false,"issuer_cik":"0001097264","issuer_name":"ALLOS THERAPEUTICS INC","issuer_ticker":"ALTH","issuer_name_source":null,"issuer_url":"/issuer/0001097264","owner_cik":"0001500322","owner_name":"Goldsmith Bruce A","owner_display_name":"Goldsmith Bruce A","owner_url":"/insider/0001500322","role":"Officer (SVP, Corporate Development)","role_mark":"O","role_mark_label":"Officer (SVP, Corporate Development)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP, Corporate Development","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4505.0,"shares_display":"4,505","price_per_share":1.5248,"price_display":"1.52","price_state":"stated","total_value":6869.224,"total_display":"6,869.22","total_whole":"6,869","shares_owned_after":351406.0,"shares_owned_after_display":"351,406","ownership_form":"D","is_10b5_1":null,"transaction_date":"2012-02-29","filed_date":"2012-03-01","scope":"insider"},{"id":3519980,"accession":"0001127602-12-008159","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001127602-12-008159","line_url":"/filing/0001127602-12-008159#line-2","is_derivative":false,"issuer_cik":"0001097264","issuer_name":"ALLOS THERAPEUTICS INC","issuer_ticker":"ALTH","issuer_name_source":null,"issuer_url":"/issuer/0001097264","owner_cik":"0001500322","owner_name":"Goldsmith Bruce A","owner_display_name":"Goldsmith Bruce A","owner_url":"/insider/0001500322","role":"Officer (SVP, Corporate Development)","role_mark":"O","role_mark_label":"Officer (SVP, Corporate Development)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP, Corporate Development","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":575.0,"shares_display":"575","price_per_share":1.5445,"price_display":"1.54","price_state":"stated","total_value":888.0875,"total_display":"888.09","total_whole":"888","shares_owned_after":176184.0,"shares_owned_after_display":"176,184","ownership_form":"D","is_10b5_1":null,"transaction_date":"2012-02-24","filed_date":"2012-02-27","scope":"insider"},{"id":3519978,"accession":"0001127602-12-008159","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001127602-12-008159","line_url":"/filing/0001127602-12-008159#line-1","is_derivative":false,"issuer_cik":"0001097264","issuer_name":"ALLOS THERAPEUTICS INC","issuer_ticker":"ALTH","issuer_name_source":null,"issuer_url":"/issuer/0001097264","owner_cik":"0001500322","owner_name":"Goldsmith Bruce A","owner_display_name":"Goldsmith Bruce A","owner_url":"/insider/0001500322","role":"Officer (SVP, Corporate Development)","role_mark":"O","role_mark_label":"Officer (SVP, Corporate Development)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP, Corporate Development","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2500.0,"shares_display":"2,500","price_per_share":1.5832,"price_display":"1.58","price_state":"stated","total_value":3958.0,"total_display":"3,958.00","total_whole":"3,958","shares_owned_after":176759.0,"shares_owned_after_display":"176,759","ownership_form":"D","is_10b5_1":null,"transaction_date":"2012-02-23","filed_date":"2012-02-27","scope":"insider"},{"id":9041673,"accession":"0001127602-11-029987","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001127602-11-029987","line_url":"/filing/0001127602-11-029987#line-2","is_derivative":false,"issuer_cik":"0001097264","issuer_name":"ALLOS THERAPEUTICS INC","issuer_ticker":"ALTH","issuer_name_source":null,"issuer_url":"/issuer/0001097264","owner_cik":"0001500322","owner_name":"Goldsmith Bruce A","owner_display_name":"Goldsmith Bruce A","owner_url":"/insider/0001500322","role":"Officer (SVP, Corporate Development)","role_mark":"O","role_mark_label":"Officer (SVP, Corporate Development)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP, Corporate Development","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":300.0,"shares_display":"300","price_per_share":1.4317,"price_display":"1.43","price_state":"stated","total_value":429.51,"total_display":"429.51","total_whole":"430","shares_owned_after":179259.0,"shares_owned_after_display":"179,259","ownership_form":"D","is_10b5_1":null,"transaction_date":"2011-11-16","filed_date":"2011-11-17","scope":"insider"},{"id":9041672,"accession":"0001127602-11-029987","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001127602-11-029987","line_url":"/filing/0001127602-11-029987#line-1","is_derivative":false,"issuer_cik":"0001097264","issuer_name":"ALLOS THERAPEUTICS INC","issuer_ticker":"ALTH","issuer_name_source":null,"issuer_url":"/issuer/0001097264","owner_cik":"0001500322","owner_name":"Goldsmith Bruce A","owner_display_name":"Goldsmith Bruce A","owner_url":"/insider/0001500322","role":"Officer (SVP, Corporate Development)","role_mark":"O","role_mark_label":"Officer (SVP, Corporate Development)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP, Corporate Development","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":12465.0,"shares_display":"12,465","price_per_share":1.4447,"price_display":"1.44","price_state":"stated","total_value":18008.1855,"total_display":"18,008.19","total_whole":"18,008","shares_owned_after":179559.0,"shares_owned_after_display":"179,559","ownership_form":"D","is_10b5_1":null,"transaction_date":"2011-11-15","filed_date":"2011-11-17","scope":"insider"},{"id":8897289,"accession":"0001127602-11-007732","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001127602-11-007732","line_url":"/filing/0001127602-11-007732#line-2","is_derivative":false,"issuer_cik":"0001097264","issuer_name":"ALLOS THERAPEUTICS INC","issuer_ticker":"ALTH","issuer_name_source":null,"issuer_url":"/issuer/0001097264","owner_cik":"0001500322","owner_name":"Goldsmith Bruce A","owner_display_name":"Goldsmith Bruce A","owner_url":"/insider/0001500322","role":"Officer (VP, Corporate Development)","role_mark":"O","role_mark_label":"Officer (VP, Corporate Development)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"VP, Corporate Development","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":507.0,"shares_display":"507","price_per_share":3.1215,"price_display":"3.12","price_state":"stated","total_value":1582.6005,"total_display":"1,582.60","total_whole":"1,583","shares_owned_after":124726.0,"shares_owned_after_display":"124,726","ownership_form":"D","is_10b5_1":null,"transaction_date":"2011-02-24","filed_date":"2011-02-25","scope":"insider"},{"id":8897287,"accession":"0001127602-11-007732","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001127602-11-007732","line_url":"/filing/0001127602-11-007732#line-1","is_derivative":false,"issuer_cik":"0001097264","issuer_name":"ALLOS THERAPEUTICS INC","issuer_ticker":"ALTH","issuer_name_source":null,"issuer_url":"/issuer/0001097264","owner_cik":"0001500322","owner_name":"Goldsmith Bruce A","owner_display_name":"Goldsmith Bruce A","owner_url":"/insider/0001500322","role":"Officer (VP, Corporate Development)","role_mark":"O","role_mark_label":"Officer (VP, Corporate Development)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"VP, Corporate Development","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2250.0,"shares_display":"2,250","price_per_share":3.25,"price_display":"3.25","price_state":"stated","total_value":7312.5,"total_display":"7,312.50","total_whole":"7,313","shares_owned_after":125233.0,"shares_owned_after_display":"125,233","ownership_form":"D","is_10b5_1":null,"transaction_date":"2011-02-23","filed_date":"2011-02-25","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":11,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":3,"open_market":true},{"code":"S","label":"Open-market sale","n":8,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":11},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001787297","name":"Passage BIO, Inc.","url":"/issuer/0001787297","role":"Director, Officer (CEO and President)","n_filings":3,"first_seen":"2020-03-03","last_seen":"2022-03-23"},{"type":"issuer","type_label":"ISSUER","cik":"0001097264","name":"ALLOS THERAPEUTICS INC","url":"/issuer/0001097264","role":"Officer (SVP, Corporate Development)","n_filings":4,"first_seen":"2011-02-25","last_seen":"2012-03-01"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001500322","retrieved_at":"2026-08-25T22:30:24+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-24","last_ingest":"2026-08-25T05:24:19.374141+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}